Table 6. Clinical features of patients received liver re-transplantation.
| Case no. | Recipient general information | Graft & surgery | Post-transplant outcome | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (years) | Gender | Primitive disease | HBV infection | Blood type | BMI (kg/m2) | Type | Degree (%) | LT-time | PCC use (U) | Operation length (min) | EAD | PNF | Treatment | Graft survival (day) | Death cause | |||
| 1 | 50 | M | HCC | Y | O | 25.5 | MaS | 35 | 1st | 10 | 337 | Y | Y | Re-transplanted | 1 | |||
| MiS | 30 | 2nd | 10 | 228 | Y | N | Dead | 136 | MODS | |||||||||
| 2 | 54 | M | HCC | Y | O | 21.9 | MiS | 10 | 1st | 0 | 319 | Y | Y | Re-transplanted | 3 | |||
| MiS | 10 | 2nd | 0 | 330 | Y | N | Alive | 559 | ||||||||||
| 3 | 64 | M | HCC | Y | O | 22.4 | MaS | 10 | 1st | 15 | 399 | Y | N | Re-transplanted | 14 | |||
| MaS | 10 | 2nd | 14 | 240 | Y | N | Dead | 4 | Graft failure | |||||||||
| 4 | 30 | M | Liver failure | N | A | 23.4 | MaS | 20 | 1st | 8 | 278 | N | Y | Re-transplanted | 3 | |||
| MaS | 20 | 2nd | 8 | 237 | N | N | Alive | 288 | ||||||||||
| 5 | 39 | M | HCC | Y | O | 22.6 | no | 0 | 1st | 0 | 329 | N | N | Re-transplanted | 15 | |||
| no | 0 | 2nd | 0 | 222 | N | N | Alive | 422 | ||||||||||
| 6 | 52 | F | Cholestatic cirrhosis | N | B | 18.0 | MiS | 20 | 1st | 0 | 239 | Y | Y | Re-transplanted | 3 | |||
| no | 0 | 2nd | 0 | 191 | Y | N | Alive | 465 | ||||||||||
BMI, body mass index; EAD, early allograft dysfunction; F, female; HCC, hepatocellular carcinoma; LT, liver transplantation; M, male; MaS, macrosteatosis; MiS, microsteatosis; MODS, multi-organ dysfunction syndrome; N, no; PCC, prothrombin complex concentrate; PNF, primary non-function; Y, yes.